" /> Resiquimod Sulfate - CISMeF





Preferred Label : Resiquimod Sulfate;

NCIt synonyms : Toll-like Receptor Agonist BDB001; TLR Agonist BDB001; TLR7/8 Agonist EIK1001; Toll-like Receptor 7/8 Agonist EIK1001; R848 Sulfate; C151008135D;

NCIt definition : The sulfate salt form of resiquimod, a toll-like receptor type 7 and 8 (TLR7/8) agonist, with potential immunostimulating and antineoplastic activities. Upon administration, resiquimod targets, binds to and activates TLR7 and 8, thereby activating TLR7/8-mediated pathways. This stimulates the maturation and activation of antigen-presenting cells (APCs), including dendritic cells (DCs). Activation of DCs results in the production of pro-inflammatory cytokines, and the activation of cytotoxic T-lymphocyte (CTL)- and B-lymphocyte-mediated immune responses. This may lead to tumor cell lysis. TLR7 and 8, members of the TLR family, play fundamental roles in the activation of the innate immune system, myeloid cell responses and tumor antigen presentation.;

UNII : C8FKIS4P1N;

CAS number : 2762439-40-5;

Molecule name : BDB-001; BDB 001; EIK 1001; EIK-1001;

NCI Metathesaurus CUI : CL563098;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.